Legend Biotech Corp ADR [LEGN] stock is trading at $22.72, up 8.29%. An important factor to consider is whether the stock is rising or falling in short-term value. The LEGN shares have gain 5.53% over the last week, with a monthly amount drifted -19.23%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on January 07, 2026, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $75. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on October 07, 2025, and set its price target to $40. On October 08, 2024, Redburn Atlantic initiated with a Buy rating and assigned a price target of $86 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $88 on June 17, 2024. H.C. Wainwright reiterated its recommendation of a Buy and reduced its price target to $73 on May 24, 2024. Deutsche Bank started tracking with a Buy rating for this stock on May 23, 2024, and assigned it a price target of $60. In a note dated April 17, 2024, Scotiabank upgraded an Sector Outperform rating on this stock but restated the target price of $65.
Legend Biotech Corp ADR [LEGN] stock has fluctuated between $20.21 and $45.30 over the past year. Currently, Wall Street analysts expect the stock to reach $63.5 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $22.72 at the most recent close of the market. An investor can expect a potential return of 179.49% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
Legend Biotech Corp ADR [NASDAQ:LEGN] reported sales of 909.83M for the trailing twelve months, which represents a growth of 70.21%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.27%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.31 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.94 points at the first support level, and at 21.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.12, and for the 2nd resistance point, it is at 23.52.
Ratios To Look Out For
For context, Legend Biotech Corp ADR’s Current Ratio is 2.86. On the other hand, the Quick Ratio is 2.80, and the Cash Ratio is 1.0. Considering the valuation of this stock, the price to sales ratio is 4.61, the price to book ratio is 4.15.
Transactions by insiders
Recent insider trading involved Huang Ying, Officer, that happened on Dec 26 ’25 when 64339.0 shares were purchased. Director, Sanders Corazon (Corsee) D. completed a deal on Dec 24 ’25 to buy 969.0 shares. Meanwhile, Officer Huang Ying bought 61467.0 shares on Dec 24 ’25.
